Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 91,517
  • Shares Outstanding, K 28,599
  • Annual Sales, $ 1,880 K
  • Annual Income, $ -60,660 K
  • EBIT $ -17 M
  • EBITDA $ -15 M
  • 60-Month Beta 0.97
  • Price/Sales 41.51
  • Price/Cash Flow N/A
  • Price/Book 8.96
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.12
  • Most Recent Earnings $-0.26 on 05/12/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +277,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.56 +25.00%
on 06/12/25
3.46 -7.51%
on 05/22/25
+0.41 (+14.70%)
since 05/16/25
3-Month
2.56 +25.00%
on 06/12/25
3.75 -14.67%
on 03/19/25
-0.50 (-13.51%)
since 03/17/25
52-Week
1.92 +66.49%
on 01/22/25
4.75 -32.63%
on 03/11/25
+0.44 (+15.94%)
since 06/17/24

Most Recent Stories

More News
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

OCX : 3.20 (+17.22%)
IMDX : 5.19 (+5.06%)
Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology

OCX : 3.20 (+17.22%)
OncoCyte: Q1 Earnings Snapshot

OncoCyte: Q1 Earnings Snapshot

OCX : 3.20 (+17.22%)
Oncocyte Reports Q1 2025 Results and Business Progress

OCX : 3.20 (+17.22%)
Oncocyte to Release First Quarter 2025 Results on May 12, 2025

OCX : 3.20 (+17.22%)
Best Momentum Stocks to Buy for May 6th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has a Zacks Rank #1 and witnessed...

OCX : 3.20 (+17.22%)
BYRN : 19.07 (+0.42%)
MAIA : 1.3450 (+9.35%)
Oncocyte Provides Positive Update on Clinical Trial Progress

OCX : 3.20 (+17.22%)
Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity

OCX : 3.20 (+17.22%)
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

OCX : 3.20 (+17.22%)
OncoCyte: Q4 Earnings Snapshot

OncoCyte: Q4 Earnings Snapshot

OCX : 3.20 (+17.22%)

Business Summary

OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

See More

Key Turning Points

3rd Resistance Point 3.87
2nd Resistance Point 3.54
1st Resistance Point 3.37
Last Price 3.20
1st Support Level 2.87
2nd Support Level 2.54
3rd Support Level 2.37

See More

52-Week High 4.75
Fibonacci 61.8% 3.67
Fibonacci 50% 3.34
Last Price 3.20
Fibonacci 38.2% 3.00
52-Week Low 1.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar